Navigation Links
Navigating Cancer Announces Jeff Oberlander as VP, Engineering
Date:1/29/2013

SEATTLE, Jan. 29, 2013 /PRNewswire/ -- Navigating Cancer is proud to announce that Jeff Oberlander has joined Navigating Cancer as VP, Engineering. Jeff has over 23 years of software engineering development and leadership expertise from a wide variety of company sizes, from 120,000-employee Fortune 500 companies to a variety of small startups in the Seattle area.

Oberlander joins a growing Navigating Cancer team, which has developed the leading patient portal in the oncology market and now delivers patient engagement solutions to nearly 600 oncologists across the United States. With a mix of healthcare and technology industry veterans, Navigating Cancer is poised to build on this leadership position and plans to grow its market share aggressively in the coming year. In his new role, Jeff will lead the engineering team to scale its current technology platform for growth and address the many business opportunities that are opening in front of the company. This will include expanding the team, as well as working towards a service-oriented architecture in order to extend the capabilities of the platform and allow for the anticipated growth of the business.

Most recently, Jeff was the Senior Director, Software Engineering for Getty Images, where he led all of Getty's Seattle eCommerce web development teams. Over the last 8 years, his teams created mission critical, 24x7, high volume eCommerce sites (80 million images, 6 million searches a day) that led to Getty's nearly $1B annual revenue. Jeff is also a passionate leader and coach in lean and agile software development best practices, which strives to bring visibility to the business value of software being created, visibility of prioritization, and a focus on the flow of work from "concept to cash." He led the transformation of Getty's 200+ IT staff to adopt these new principles and processes.

"We've been searching for the right engineering leader for over a year," said Gena Cook , Navigating Cancer CEO. "We're excited to have Jeff's leadership, expertise, vision and passion to help scale our business to better serve the healthcare professionals and patients we serve every day."

"I am thrilled to have this chance to work in such a meaningful and personal business. Everyone I know has been touched in some way by cancer, and this business helps cancer patients manage their care in a way that wasn't available previously. The business is growing quickly and customers are signing up at a rapid pace — yet it has all of the fun of a new startup where everyone contributes to the bottom line and wears many hats. It is exciting to be able to apply the breadth of my technology experience to a new growing Seattle business, and one that will make a difference to others," said Oberlander.

About Navigating Cancer

Navigating Cancer's mission is to transform healthcare through patient centered care by using technology to connect cancer patients to their healthcare team, their own health records, and the right information at the right time. Navigating Cancer's Patient Engagement Portal provides oncology clinics with a branded, online extension of their care model, empowering them to save time and money while providing better quality care. The company was founded in 2008 by technology and healthcare veterans and is based in Seattle, Washington.


'/>"/>
SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
4. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
5. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
6. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
7. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
8. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
9. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
10. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):